Thu, June 19, 2025
Wed, June 18, 2025
Tue, June 17, 2025
[ Last Tuesday ]: MLB
Yankees Mag: Life Sciences
Mon, June 16, 2025
Sun, June 15, 2025
Sat, June 14, 2025
[ Last Saturday ]: BBC
What is a shallow earthquake?
Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
[ Mon, May 26th ]: Forbes
Is Science Slowing Down?
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025

New neuro company raises $140M for depression drug


//science-technology.news-articles.net/content/2 .. uro-company-raises-140m-for-depression-drug.html
Published in Science and Technology on by STAT   Print publication without navigation

And other biotech news stories brought to you by The Readout.

The article from STAT News dated June 18, 2025, discusses several key developments in the biotech industry. It highlights Dr. Marty Makary's new book on the future of medicine, which emphasizes personalized treatments and the integration of AI in healthcare. The article also covers Draig Pharmaceuticals' promising results from their Phase 2 trial of a novel psychedelic compound aimed at treating depression, showing significant improvements in patient outcomes. Additionally, it mentions BioVaccines' advancement in developing a universal flu vaccine, which has entered Phase 3 trials. The piece concludes with a brief mention of The Readout newsletter, which provides weekly updates on biotech and pharmaceutical news.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/06/18/biotech-news-makary-draig-psychedelics-depression-bio-vaccines-the-readout/ ]

Publication Contributing Sources